Abbott Laboratories (ABT) Other Operating Expenses (2009 - 2026)

Abbott Laboratories has disclosed Other Operating Expenses across 18 years of filings, most recently posting $6.0 billion for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 13.44% year-over-year to $6.0 billion; the TTM figure through Jun 2026 stood at $22.1 billion (up 6.74% YoY), while the FY2025 annual figure was $21.0 billion, up 2.03% from the prior year.
• Other Operating Expenses came in at $6.0 billion for Q2 2026 at Abbott Laboratories, up from $5.3 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $6.0 billion in Q2 2026 to a low of $4.8 billion in Q1 2023.
• Average Other Operating Expenses over 5 years is $5.2 billion, with a median of $5.1 billion recorded in 2022.
• Year-over-year, Other Operating Expenses declined 12.31% in 2023 and rose 13.44% in 2026.
• Over 5 years, Other Operating Expenses stood at $5.1 billion in 2022, then dropped by 1.02% to $5.0 billion in 2023, then grew by 7.35% to $5.4 billion in 2024, then dropped by 1.17% to $5.3 billion in 2025, then grew by 11.96% to $6.0 billion in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $6.0 billion in Q2 2026, $5.3 billion in Q1 2026, and $5.3 billion in Q4 2025.